Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New study investigates use of soy-rich diet for preventing chronic pain after breast cancer surgery

01.09.2010
The potential health benefits associated with a soy-rich diet have been a source of interest and debate for many years. Several studies have hinted at its great potential for relieving post-traumatic and osteopathic pain. Now, a breakthrough study, focusing on the benefits of soy in the prevention of chronic pain after breast cancer surgery, has been launched by researchers at the Alan Edwards Pain Management Unit of the McGill University Health Centre (MUHC) and McGill University.

“If we can demonstrate that a soy-rich pre-surgery diet, is both safe and effective for the prevention of chronic post-surgical pain, the clinical implications will be significant and could help many women around the world,” explains Dr. Yoram Shir, principal investigator of the study and Director of the MUHC Alan Edwards Pain Management Unit, who is also a Professor of Anesthesia and Edwards Chair in Clinical Pain at McGill University.

Chronic pain after breast cancer surgery is the most common cause for long-term morbidity in women diagnosed with breast cancer, with an incidence that can be higher than 50%. This pain can be resistant to treatment and last for years, burdening women with its physical, emotional and social consequences. This new National Institutes of Health-funded study will determine if a diet enriched with soy protein, consumed by women for two weeks prior to surgery, could prevent the development of chronic pain. "If shown to be efficacious, this would be a natural and safe preventive treatment that is easily incorporated into the everyday diet,” says Dr. Shir. Our daily diet can also be enriched with soy protein through shelf products like tofu and soy milk.

There is currently no proven effective method for the prevention of chronic postoperative pain," explains Dr. Shir. “Measures such as pain-relieving medications, commonly used to relieve acute pain after surgery, are largely ineffective in preventing acute post-surgical pain from becoming chronic.” Over 22,000 new cases of breast cancer in women are diagnosed each year in Canada and 6,000 in Quebec; most will undergo surgery as part of their comprehensive cancer therapy.

Dr. Shir will be attending the 13th World Congress on Pain in Montreal from August 20 to September 2, 2010. www.iasp-pain.org/

About the Study
www.clinicaltrials.gov/ct2/show/NCT01047774?term=soy-rich+diet&rank=1
For more information on this study, or to participate please contact the office of Dr. Yoram Shir (principal investigator) at 514- 934-8222 or by email: yoram.shir@muhc.mcgill.ca

About the McGill University Health Centre (MUHC) One of the world’s foremost academic health centres, the MUHC offers exceptional and integrated patient-centric care, research and teaching. Highly committed to the continuum of care in its community and affiliated with the Faculty of Medicine of McGill University, The Montreal Children's Hospital, the Montreal General Hospital, the Royal Victoria Hospital, the Montreal Neurological Hospital, the Montreal Chest Institute and the Lachine Hospital of the MUHC value multidisciplinary service throughout the lifespan, innovative technologies and practices, strategic partnerships and leadership in knowledge transfer. The MUHC is currently carrying out a $2.25-billion Redevelopment Project on three campuses—the Mountain, the Glen and Lachine—designed to provide healthcare professionals with an effective environment in which to ensure patients and their families benefit from The Best Care for Life. The campuses are also anchored in best sustainable-development practices, including LEED® and BOMA BESt guidelines.

www.muhc.ca www.muhc.ca/construction

The Alan Edwards Pain Management Unit is a bilingual, hospital-based, interdisciplinary facility serving the MUHC, the greater Montreal community, surrounding areas and other regions of Quebec and eastern Ontario. The Unit attends to patients suffering cancerous and non-cancerous pain of any origin. Its objectives to relieve pain, to restore function and improve quality of life, are met through the combined efforts of a team of pain specialists and researchers from diverse health-care disciplines.

The Research Institute of the McGill University Health Centre (RI MUHC) is a world-renowned biomedical and health-care hospital research centre. Research is organized by eleven research axes (or programs). Located in Montreal, Quebec, Canada, the Institute is the research arm of the McGill University Health Centre affiliated with the Faculty of Medicine at McGill University. The Institute supports over 600 researchers, over 1,800 graduate students and post-docs and fellows devoted to a broad spectrum of fundamental and clinical research. Over 1000 clinical research studies are conducted within our hospitals each year. The Research Institute of the MUHC is supported in part by the Fonds de la recherche en santé du Québec (FRSQ).

www.muhc.ca/research/

About McGill University
McGill University, founded in Montreal, Que., in 1821, is Canada’s leading post-secondary institution. It has two campuses, 11 faculties, 10 professional schools, 300 programs of study and more than 35,000 students. McGill attracts students from more than 150 countries around the world. Almost half of McGill students claim a first language other than English – including 6,200 francophones – with more than 6,800 international students making up almost 20 per cent of the student body.

www.mcgill.ca

Media contact:

Julie Robert
Communications Coordinator (Research)
Public Affairs and Strategic Planning, MUHC
Phone: 514 934-1934 ext. 71381
E-mail: julie.robert@muhc.mcgill.ca

Julie Robert | MUHC
Further information:
http://www.muhc.mcgill.ca
http://www.muhc.ca/research/

More articles from Studies and Analyses:

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

nachricht Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

What the world's tiniest 'monster truck' reveals

23.08.2017 | Life Sciences

Treating arthritis with algae

23.08.2017 | Life Sciences

Witnessing turbulent motion in the atmosphere of a distant star

23.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>